Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: A modeling study
From The Lancet Infectious Diseases
https://www.thelancet.com/action/showPdf?pii=S1473-3099%2818%2930804-1